IP Library Granted Patent US 8,369,952
Granted Patent B2
US 8,369,952 · App. 13/178,221 · Granted Feb 5, 2013

Bulimia treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,369,952
App. No.
13/178,221
Granted
Feb 5, 2013
Kind
B2
Abstract

At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning an electrode on a vagus nerve. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. In some embodiments, the disorder is gastroparesis. The signal may be a blocking or a stimulation signal. In some embodiments, the signal is selected to a) at least in part, upregulate neural activity on the vagus nerve without triggering muscular contractility, and, b) increase pancreobilliary output.

Claims (9)

1. A method for treating gastroparesis comprising:

positioning at least one first electrode on a vagus nerve at a site below a vagal innervation of a heart of a patient having gastroparesis, with the nerve innervating at least one of a plurality of alimentary tract organs; and

treating the patient's gastroparesis by instructing an implantable device to apply an electrical signal to the electrode intermittently and not in response to a sensed event, wherein the electrical signal is selected to a) at least in part, upregulate neural activity on the vagus nerve without triggering muscular contractility, and, b) increase pancreatic and biliary output via stimulation of pancreo-biliary output.

2. A method according to claim 1 wherein application of the electrical signal is varied by a controller to alter a characteristic of the electrical signal.

3. A method according to claim 1 wherein the first electrode is placed at the vagus nerve at an esophagus of the patient.

4. A method according to claim 1 wherein the signal has a frequency of about 12 Hz.

5. A method according to claim 1 wherein the signal is applied to a trunk of the vagus nerve.

6. A method according to claim 1 wherein the signal is applied to a branch of the vagus nerve.

7. A method according to claim 1 wherein the signal is applied to both an anterior vagus nerve and a posterior vagus nerve of the patient.

Assignments (2)
SECURITY INTEREST Recorded Jun 19, 2020
From: RESHAPE LIFESCIENCES INC.; RESHAPE MEDICAL LLC
To: ARMISTICE CAPITAL MASTER FUND LTD.
Reel/Frame 052987/0463 →
CHANGE OF NAME Recorded Mar 30, 2018
From: ENTEROMEDICS INC.
To: RESHAPE LIFESCIENCES INC.
Reel/Frame 045949/0495 →